Key result
EVOQUE transcatheter tricuspid replacement succeeds in complex congenital heart disease with a transvalvular lead.
Why the study?
Severe tricuspid regurgitation in patients with complex congenital heart disease and prohibitive surgical risk is often undertreated, and treatment options are limited.
Does transcatheter tricuspid valve replacement improve symptoms and tricuspid regurgitation severity in a high-risk patient with complex adult congenital heart disease and a pacing lead?
Case Report (n=1)
No
Does transcatheter tricuspid valve replacement improve symptoms and tricuspid regurgitation severity in a high-risk patient with complex adult congenital heart disease and a pacing lead?
Answers are grounded in this paper and cite their sources.
Transcatheter tricuspid valve replacement is feasible and can improve symptoms in patients with complex adult congenital heart disease and torrential tricuspid regurgitation complicated by transvalvular pacing leads.
BACKGROUND: Severe tricuspid regurgitation (TR) carries high morbidity and is often undertreated in patients with complex congenital heart disease and prohibitive surgical risk. CASE SUMMARY: A 33-year-old woman with complex congenital heart disease and multiple prior surgeries presented with progressive right-sided heart failure and torrential TR. Imaging demonstrated septal leaflet splinting by a transvenous pacing lead. She was unsuitable for surgery or transcatheter edge-to-edge repair. Following Heart Team assessment, transcatheter tricuspid valve replacement with a 48 mm EVOQUE valve (Edwards Lifesciences) was performed. Despite procedural challenges including delivery system septal bias, implantation was successful with mild residual TR and early symptomatic improvement. DISCUSSION: Transcatheter tricuspid valve replacement is an emerging option for high-risk patients. This case demonstrates feasibility in complex congenital anatomy with pacing leads, a group under-represented in current evidence. TAKE-HOME MESSAGES: Transcatheter tricuspid valve replacement expands treatment options in high-risk congenital tricuspid regurgitation. Careful imaging and Heart Team planning are essential for success.
No takes yet. Share an insight, caveat, or question.
Morris et al. (2026) conducted a case report in Torrential tricuspid regurgitation in complex adult congenital heart disease (n=1). Transcatheter tricuspid valve replacement (48 mm EVOQUE valve) was evaluated on Procedural success and early symptomatic improvement. Transcatheter tricuspid valve replacement with an EVOQUE valve was successfully performed in a patient with complex congenital heart disease and a transvalvular pacing lead, resulting in mild residual tricuspid regurgitation and early symptomatic improvement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: